NASDAQ:BMRN
$97.24
(
2.05%
)
Friday, 31st Mar 2023
BioMarin Pharmaceutical Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $87.34 | $102.79 | Friday, 31st Mar 2023 BMRN stock ended at $97.24. This is 2.05% more than the trading day before Thursday, 30th Mar 2023. During the day the stock fluctuated 2.23% from a day low at $95.56 to a day high of $97.70. |
| 90 days | $87.34 | $117.77 | |
| 52 weeks | $70.73 | $117.77 |
Historical BioMarin Pharmaceutical Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2021-06-17 | $82.54 | $83.76 | $82.04 | $82.98 | 820 917 |
| 2021-06-16 | $82.13 | $82.68 | $81.35 | $82.48 | 1 028 627 |
| 2021-06-15 | $82.40 | $82.76 | $81.19 | $81.96 | 549 905 |
| 2021-06-14 | $82.49 | $83.45 | $82.17 | $82.48 | 632 335 |
| 2021-06-11 | $83.55 | $83.85 | $81.75 | $82.07 | 743 066 |
| 2021-06-10 | $82.46 | $84.14 | $81.83 | $83.67 | 1 088 597 |
| 2021-06-09 | $79.46 | $82.50 | $79.27 | $82.05 | 1 319 356 |
| 2021-06-08 | $79.17 | $79.27 | $78.00 | $78.76 | 614 270 |
| 2021-06-07 | $78.01 | $79.90 | $77.47 | $78.66 | 900 716 |
| 2021-06-04 | $77.73 | $78.44 | $77.34 | $77.89 | 514 923 |
| 2021-06-03 | $77.42 | $77.47 | $76.24 | $77.36 | 528 860 |
| 2021-06-02 | $77.83 | $77.98 | $76.73 | $77.35 | 1 133 143 |
| 2021-06-01 | $77.52 | $77.87 | $76.75 | $77.69 | 750 222 |
| 2021-05-28 | $77.28 | $78.20 | $77.10 | $77.30 | 573 473 |
| 2021-05-27 | $77.35 | $77.60 | $76.04 | $77.36 | 1 417 555 |
| 2021-05-26 | $77.65 | $78.17 | $76.84 | $77.28 | 833 365 |
| 2021-05-25 | $77.26 | $77.91 | $76.58 | $77.60 | 757 067 |
| 2021-05-24 | $78.62 | $78.90 | $77.47 | $77.55 | 563 283 |
| 2021-05-21 | $78.97 | $79.15 | $77.80 | $78.10 | 742 839 |
| 2021-05-20 | $76.54 | $79.38 | $76.54 | $79.12 | 1 072 758 |
| 2021-05-19 | $76.79 | $77.09 | $75.76 | $76.42 | 746 986 |
| 2021-05-18 | $77.39 | $79.02 | $77.00 | $77.67 | 621 850 |
| 2021-05-17 | $76.60 | $77.97 | $75.75 | $77.34 | 548 505 |
| 2021-05-14 | $76.01 | $77.52 | $75.59 | $76.93 | 932 963 |
| 2021-05-13 | $75.96 | $76.73 | $74.63 | $75.51 | 678 988 |
| 2021-05-12 | $75.27 | $76.45 | $75.21 | $75.60 | 769 520 |
| 2021-05-11 | $74.66 | $77.00 | $74.43 | $75.69 | 792 843 |
| 2021-05-10 | $77.29 | $77.70 | $75.81 | $76.39 | 710 482 |
| 2021-05-07 | $79.00 | $79.83 | $77.07 | $77.77 | 625 110 |
| 2021-05-06 | $78.00 | $79.00 | $77.34 | $78.61 | 774 743 |
| 2021-05-05 | $78.14 | $79.10 | $77.20 | $77.68 | 867 227 |
| 2021-05-04 | $78.71 | $78.79 | $77.25 | $78.35 | 896 823 |
| 2021-05-03 | $78.30 | $79.28 | $77.62 | $78.68 | 812 874 |
| 2021-04-30 | $79.69 | $79.85 | $77.24 | $77.92 | 1 445 936 |
| 2021-04-29 | $81.29 | $81.75 | $79.68 | $80.18 | 726 844 |
| 2021-04-28 | $80.00 | $80.66 | $79.49 | $80.46 | 529 403 |
| 2021-04-27 | $81.00 | $81.28 | $79.64 | $79.77 | 867 461 |
| 2021-04-26 | $79.20 | $81.41 | $78.61 | $81.16 | 786 134 |
| 2021-04-23 | $79.34 | $80.19 | $78.60 | $78.73 | 719 660 |
| 2021-04-22 | $78.91 | $80.18 | $78.29 | $79.70 | 701 877 |
| 2021-04-21 | $79.80 | $79.80 | $78.07 | $79.33 | 921 118 |
| 2021-04-20 | $79.51 | $80.59 | $79.03 | $79.45 | 722 950 |
| 2021-04-19 | $79.58 | $79.95 | $79.01 | $79.59 | 974 383 |
| 2021-04-16 | $79.12 | $79.60 | $78.07 | $79.40 | 867 973 |
| 2021-04-15 | $76.72 | $79.64 | $76.72 | $78.77 | 1 253 180 |
| 2021-04-14 | $78.25 | $79.35 | $77.98 | $78.23 | 664 757 |
| 2021-04-13 | $77.44 | $78.29 | $76.50 | $77.77 | 863 490 |
| 2021-04-12 | $76.56 | $77.45 | $76.38 | $77.11 | 786 870 |
| 2021-04-09 | $78.02 | $78.79 | $76.47 | $77.07 | 760 442 |
| 2021-04-08 | $78.45 | $78.92 | $77.95 | $78.23 | 903 631 |
About BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
